Research and Markets recently launched the “In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028” report, providing an in-depth analysis of In Vitro Diagnostic (IVD) test volumes on a global scale.
This comprehensive report serves as a vital resource for both new entrants seeking opportunities and existing product marketers navigating the dynamic diagnostic industry landscape.
The report focuses on IVD procedure volumes, emphasizing commercially sold and distributed tests while excluding laboratory-developed and research-specific tests. It presents global volumes across various IVD procedures, encompassing self and professional point-of-care, clinical chemistry, immunoassay, molecular, hematology, coagulation, microbiology, blood banking, and histology/cytology.
The sales of IVD products are meticulously detailed in current USD, providing a reflection of sales for the year 2023 and forecasts extending to the period of 2028. The projections include the total number of IVD procedures, the total IVD tests categorized by region and selected countries, as well as the average and total worldwide cost of various IVD tests.
Insights Into IVD Testing Segments
The report delves into trends and growth projections for specific IVD testing segments. These include point-of-care procedures, clinical chemistry, immunoassays, molecular testing, laboratory-based hematology, coagulation testing, microbiology procedures, blood grouping/typing, and histology/cytology procedures.
Regional Market Analysis
Detailed regional market analyses cover North America, Central & South America, Western Europe, Eastern Europe, Asia/Pacific, China, Japan, the Middle East, and Africa. This provides a comprehensive view of the global IVD landscape, highlighting regional variations and opportunities.
Detailed Company Profiles
The report features detailed profiles of key companies shaping the IVD industry. Abbott Diagnostics, Agilent Technologies, Beckman Coulter, bioMerieux Inc., Roche Diagnostics, Siemens Healthineers, and others are extensively covered, offering insights into their contributions and market presence.
Looking ahead, the report provides projections for the 2023-2028 period, encompassing the total number of IVD procedures, IVD tests by region and selected countries, and the average and total worldwide cost of various IVD tests. This forward-looking perspective aids industry stakeholders in strategic planning and decision-making.